alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
IB 

Union Calendar No. 492 

116TH CONGRESS 

2D SESSION H. R. 4153 

[Report No. 116–599, Part I] 

To amend the Indian Health Care Improvement Act to authorize urban 

Indian organizations to enter into arrangements for the sharing of medical services and facilities, and for other purposes. 

IN THE HOUSE OF REPRESENTATIVES 

AUGUST 2, 2019 

Mr. KHANNA (for himself, Mr. GOSAR, Ms. HAALAND, Mr. GIANFORTE, Mr. 

LUJA ́N, Mr. YOUNG, Ms. MOORE, Mr. BACON, Mr. TONKO, and Mr. 

ESTES) introduced the following bill; which was referred to the Committee on Natural Resources, and in addition to the Committee on Energy and Commerce, for a period to be subsequently determined by the 

Speaker, in each case for consideration of such provisions as fall within 

the jurisdiction of the committee concerned 

NOVEMBER 19, 2020 

Additional sponsors: Mr. GALLEGO, Mr. BLUMENAUER, Mr. KILMER, Mr. 

HASTINGS, Mr. O’HALLERAN, Mr. COOK, Ms. ROYBAL-ALLARD, Mr. 

FITZPATRICK, Mrs. KIRKPATRICK, Mrs. RODGERS of Washington, Mr. 

COLE, Ms. DEGETTE, Mr. AGUILAR, Mr. MULLIN, Mr. JOYCE of Ohio, 

Ms. SEWELL of Alabama, Mr. KILDEE, and Ms. KENDRA S. HORN of 

Oklahoma 

NOVEMBER 19, 2020 

Reported from the Committee on Natural Resources 

NOVEMBER 19, 2020 

Committee on Energy and Commerce discharged; committed to the Committee 

of the Whole House on the State of the Union and ordered to be printed 


pamtmann on DSKBC07HB2PROD with BILLS
2 

•HR 4153 RH

A BILL 

To amend the Indian Health Care Improvement Act to authorize urban Indian organizations to enter into arrangements for the sharing of medical services and facilities, 

and for other purposes. 


pamtmann on DSKBC07HB2PROD with BILLS
3 

•HR 4153 RH

1 Be it enacted by the Senate and House of Representa2 tives of the United States of America in Congress assembled, 

3 SECTION 1. SHORT TITLE. 

4 This Act may be cited as the ‘‘Health Care Access 

5 for Urban Native Veterans Act’’. 

6 SEC. 2. SHARING ARRANGEMENTS WITH FEDERAL AGEN7 CIES. 

8 Section 405 of the Indian Health Care Improvement 

9 Act (25 U.S.C. 1645) is amended— 

10 (1) in subsection (a)(1), by inserting ‘‘urban In11 dian organizations,’’ before ‘‘and tribal organiza12 tions’’; and 

13 (2) in subsection (c)— 

14 (A) by inserting ‘‘urban Indian organiza15 tion,’’ before ‘‘or tribal organization’’; and 

16 (B) by inserting ‘‘an urban Indian organi17 zation,’’ before ‘‘or a tribal organization’’. 


pamtmann on DSKBC07HB2PROD with BILLS
Union Calendar No. 492 

116TH CONGRESS 

2D SESSION H. R. 4153 

[Report No. 116–599, Part I] 

A BILL 

To amend the Indian Health Care Improvement 

poses. ical services and facilities, and for other purenter into arrangements for the sharing of medAct to authorize urban Indian organizations to 

NOVEMBER 19, 2020 

Reported from the Committee on Natural Resources 

NOVEMBER 19, 2020 

Committee on Energy and Commerce discharged; comState of the Union and ordered to be printed mitted to the Committee of the Whole House on the 


pamtmann on DSKBC07HB2PROD with BILLS
**Exhibit 31.1****CERTIFICATION OF CHIEF EXECUTIVE OFFICER****PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002**I, David L. Turney, certify that:1. I have reviewed this quarterly report on Form 10-Q of DRI Corporation; 2. Based on my knowledge, this report does not contain any untrue statement of a material factor omit to state a material fact necessary to make the statements made, in light of thecircumstances under which such statements were made, not misleading with respect to the periodcovered by this report; 3. Based on my knowledge, the financial statements, and other financial information included inthis report, fairly present in all material respects the financial condition, results ofoperations and cash flows of the registrant as of, and for, the periods presented in thisreport; 4. The registrant’s other certifying officer and I are responsible for establishing andmaintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and15d-15(e)) for the registrant and we have: A) designed such disclosure controls and procedures, or caused such disclosure controlsand procedures to be designed under our supervision, to ensure that material informationrelating to the registrant, including its consolidated subsidiaries, is made known to us byothers within those entities, particularly during the period in which this report is beingprepared;  B) evaluated the effectiveness of the registrant’s disclosure controls and procedures andpresented in this report our conclusions about the effectiveness of the disclosure controlsand procedures, as of the end of the period covered by this report based on suchevaluation; and  C) disclosed in this report any change in the registrant’s internal control over financialreporting that occurred during the registrant’s most recent fiscal quarter (theregistrant’s fourth fiscal quarter in the case of an annual report) that has materiallyaffected, or is reasonably likely to materially affect, the registrant’s internal controlover financial reporting.5. The registrant’s other certifying officer and I have disclosed, based on our most recentevaluation of internal control over financial reporting, to the registrant’s auditors and theaudit committee of the registrant’s board of directors (or persons performing the equivalentfunctions): A) all significant deficiencies and material weaknesses in the design or operation ofinternal control over financial reporting which are reasonably likely to adversely affectthe registrant’s ability to record, process, summarize and report financial information;and  B) any fraud, whether or not material, that involves management or other employees whohave a significant role in the registrant’s internal control over financial reporting.   /s/ David L. Turney David L. Turney  Chief Executive Officer  August 14, 2007  A signed copy of this written statement required by Section 302 has been provided to the Companyand will be retained by the Company and furnished to the Securities and Exchange Commission or itsstaff upon request.
I 

116TH CONGRESS 

1ST SESSION H. R. 4233 

To require the Federal banking agencies to increase the risk-sensitivity of 

the capital treatment of certain centrally cleared exchange-listed derivatives, and for other purposes. 

IN THE HOUSE OF REPRESENTATIVES 

SEPTEMBER 6, 2019 

Mr. GOODEN introduced the following bill; which was referred to the 

Committee on Financial Services 

A BILL 

To require the Federal banking agencies to increase the 

risk-sensitivity of the capital treatment of certain centrally cleared exchange-listed derivatives, and for other 

purposes. 

1 Be it enacted by the Senate and House of Representa2 tives of the United States of America in Congress assembled, 

3 SECTION 1. SHORT TITLE. 

4 This Act may be cited as the ‘‘Options Market Sta5 bility Act of 2019’’. 

6 SEC. 2. DERIVATIVE CONTRACTS. 

7 (a) DEFINITIONS.—In this section, the terms ‘‘depos8 itory institution’’ and ‘‘depository institution holding comVerDate Sep 11 2014 21:28 Sep 06, 2019 Jkt 089200 PO 00000 Frm 00001 Fmt 6652 Sfmt 6201 E:\BILLS\H4233.IH H4233

pamtmann on DSKBC07HB2PROD with BILLS
2 

•HR 4233 IH

1 pany’’ have the meanings given those terms in section 3 

2 of the Federal Deposit Insurance Act (12 U.S.C. 1813). 

3 (b) REQUIREMENT.—Not later than December 31, 

4 2019, the Board of Governors of the Federal Reserve Sys5 tem, the Federal Deposit Insurance Corporation, and the 

6 Comptroller of the Currency shall— 

7 (1) jointly issue a final rule relating to the no8 tice of proposed rule making entitled ‘‘Standardized 

9 Approach for Calculating the Exposure Amount of 

10 Derivative Contracts’’ (83 Fed. Reg. 64660; Decem11 ber 17, 2018); or 

12 (2) implement relief that allows for the adop13 tion of a methodology for calculating the 

14 counterparty credit risk exposure, at default, of a 

15 depository institution, depository institution holding 

16 company, or affiliate thereof to a client arising from 

17 a guarantee provided by the depository institution, 

18 depository institution holding company, or affiliate 

19 thereof to a central counterparty in respect of the 

20 client’s performance under an exchange-listed deriv21 ative contract cleared through that central 

22 counterparty pursuant to the risk-based and lever23 age-based capital rules applicable to depository insti24 tutions and depository institution holding companies 

25 under parts 3, 217, and 324 of title 12, Code of 


pamtmann on DSKBC07HB2PROD with BILLS
3 

•HR 4233 IH

1 Federal Regulations, that reflects the economic value 

2 of delta weighting and netting. 

Æ 


pamtmann on DSKBC07HB2PROD with BILLS
```

[Congressional Bills 116th Congress]
[From the U.S. Government Publishing Office]
[H.R. 4202 Introduced in House (IH)]

<DOC>

116th CONGRESS
  1st Session
                                H. R. 4202

To amend the Immigration and Nationality Act to clarify the officers of 
  U.S. Customs and Border Protection are authorized to conduct asylum 
                  interviews, and for other purposes.

_______________________________________________________________________

                    IN THE HOUSE OF REPRESENTATIVES

                            August 23, 2019

Mr. Arrington introduced the following bill; which was referred to the 
                       Committee on the Judiciary

_______________________________________________________________________

                                 A BILL

 
To amend the Immigration and Nationality Act to clarify the officers of 
  U.S. Customs and Border Protection are authorized to conduct asylum 
                  interviews, and for other purposes.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. SHORT TITLE.

    This Act may be cited as the ``Securing Comprehensive Review in 
Entry Enforcement Now Act of 2019'' or the ``SCREEN Act of 2019''.

SEC. 2. OFFICERS OF U.S. CUSTOMS AND BORDER PROTECTION AUTHORIZED TO 
              CONDUCT ASYLUM INTERVIEWS.

    Section 235(b)(1)(E) of the Immigration and Nationality Act (8 
U.S.C. 1225(b)(1)(E)) is amended in the matter preceding clause (i), by 
inserting ``, including an officer of U.S. Customs and Border 
Protection,'' after ``immigration officer''.
                                 <all>
```
Michelle GONZALEZ, petitioner, v. FLORIDA.

No. 17-382.

Supreme Court of the United States

Nov. 27, 2017.

Petition for writ of certiorari to the District Court of Appeal of Florida, Second District denied.
Ali R. HASHEMI-NEJAD, petitioner, v. Mina Kompani HASHEMI.

No. 17-196.

Supreme Court of the United States

Oct. 10, 2017.

Petition for writ of certiorari to the Supreme Court of North Carolina denied.
[Federal Register Volume 66, Number 126 (Friday, June 29, 2001)]
[Notices]
[Page 34698]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 01-16360]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Center for Complementary & Alternative Medicine; Notice 
of Closed Meeting

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. Appendix 2), notice is hereby given of the following 
meeting.
    The meeting will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Center for Complementary and 
Alternative Medicine Special Emphasis Panel, NCCAM SEP C-13.
    Date: July 2, 2001.
    Time: 1:30 pm to 3:30 pm.
    Agenda: To review and evaluate grant applications.
    Place: 2 Democracy Plaza, 6707 Democracy Boulevard, 6th Floor, 
Room 647, Bethesda, MD 20892, (Telephone Conference Call).
    Contact Person: John C. Chah, Scientific Review Administrator, 
National Center for Complementary and Alternative Medicine, National 
Institutes of Health, 6707 Democracy Boulevard, Rm. 106, Bethesda, 
MD 20892-5495, 301-402-4334.
    This notice is being published less than 15 days prior to the 
meeting due to the timing limitations imposed by the review and 
funding cycle.


    Dated: June 21, 2001.
LaVerne Y. Stringfield,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. 01-16360 Filed 6-28-01; 8:45 am]
BILLING CODE 4140-01-M
Gregory Lynn CROSS, petitioner, v. UNITED STATES.

No. 17-6034.

Supreme Court of the United States

Oct. 30, 2017.

Petition for writ of certiorari to the United States Court of Appeals for the Ninth Circuit denied.
## SUPREME COURT OF THE STATE OF NEW YORK 

## Appellate Division, Fourth Judicial Department

**1071 CAF 11-01094** 
PRESENT: SCUDDER, P.J., SMITH, CENTRA, GREEN, AND GORSKI, JJ.

IN THE MATTER OF MARK D. COLEMAN, PETITIONER-APPELLANT,

V MEMORANDUM AND ORDER

MAUREEN M. MURPHY, RESPONDENT-RESPONDENT.

BUCCI LAW FIRM, PLLC, BALDWINSVILLE (ROSEMARY E. BUCCI OF COUNSEL), FOR PETITIONER-APPELLANT.

JOHN M. MURPHY, JR., PHOENIX, FOR RESPONDENT-RESPONDENT.

LISA M. FAHEY, ATTORNEY FOR THE CHILD, EAST SYRACUSE, FOR CASEY M.C.

Appeal from an order of the Family Court, Onondaga County (William Dowling, R.), entered November 16, 2010 in a proceeding pursuant to Family Court Act article 4. The order dismissed the petition.

It is hereby ORDERED that the order so appealed from is unanimously reversed on the law without costs, the petition is reinstated, and the matter is remitted to Family Court, Onondaga County, for further proceedings in accordance with the following Memorandum: Petitioner father commenced this proceeding pursuant to Family Court Act article 4 seeking to terminate his support obligation for the parties’ son on the grounds that respondent mother had frustrated the father’s visitation rights and that his son had abandoned him. The father appeals from an order dismissing his petition without prejudice “for lack of proper cause of action for filing.” We agree with the father that the Referee erred in dismissing the petition without conducting a hearing. Indeed, the Referee was required to “conduct a hearing on [the] petition to modify a support order where the petition [was] ‘supported by affidavit and other evidentiary material sufficient to establish a prima facie case for the relief requested.’ Here, [the father] established a prima facie case for the relief requested with respect to child support by submitting evidentiary material establishing that his [son] had abandoned him. His submissions in support of the petition established that his repeated attempts at communication with his [son] had been refused and that [he] had expressed a clear wish to ‘have nothing to do with’ ” the father ( Matter of Garcia v Barie , 59 AD3d 1090; see Matter of Saunders v Aiello , 59 AD3d 1090, 1091; cf. Matter of Hootnick v Cohen , 193 AD2d 1092). In addition, the petition alleged that the mother had refused to permit the father to exercise his**-2- 1071 CAF 11-01094** 

visitation rights, and “a custodial parent’s ‘deliberate frustration’ of visitation rights can, under appropriate circumstances, warrant the suspension of future child support payments” ( Hiross v Hiross , 224 AD2d 662, 663). Consequently, we reverse the order, reinstate the petition, and remit the matter to Family Court for further proceedings thereon.

Entered: November 18, 2011 Patricia L. Morgan Clerk of the Court
# L_2012161EN.01001701.xml

| 21.6.2012 | EN | Official Journal of the European Union | L 161/17 |
| --- | --- | --- | --- |

21.6.2012

EN

Official Journal of the European Union

L 161/17

---

DECISION OF THE EEA JOINT COMMITTEE

No 11/2012

of 10 February 2012

amending Annex II (Technical regulations, standards, testing and certification) to the EEA Agreement

THE EEA JOINT COMMITTEE,

Having regard to the Agreement on the European Economic Area, as amended by the Protocol adjusting the Agreement on the European Economic Area, hereinafter referred to as ‘the Agreement’, and in particular Article 98 thereof,

Whereas:

| (1) | Annex II to the Agreement was amended by Decision of the EEA Joint Committee No 51/2011 of 20 May 2011 (1). |
| --- | --- |

(1)

Annex II to the Agreement was amended by Decision of the EEA Joint Committee No 51/2011 of 20 May 2011 (1).

| (2) | Commission Regulation (EU) No 137/2011 of 16 February 2011 amending Regulation (EC) No 2003/2003 of the European Parliament and of the Council relating to fertilisers for the purposes of adapting Annexes I and IV thereto to technical progress (2) is to be incorporated into the Agreement, |
| --- | --- |

(2)

Commission Regulation (EU) No 137/2011 of 16 February 2011 amending Regulation (EC) No 2003/2003 of the European Parliament and of the Council relating to fertilisers for the purposes of adapting Annexes I and IV thereto to technical progress (2) is to be incorporated into the Agreement,

HAS ADOPTED THIS DECISION:

Article 1

The following indent shall be added in point 1 (Regulation (EC) No 2003/2003 of the European Parliament and of the Council) of Chapter XIV of Annex II to the Agreement:

| ‘— | 32011 R 0137: Commission Regulation (EU) No 137/2011 of 16 February 2011 (OJ L 43, 17.2.2011, p. 1).’. |
| --- | --- |

‘—

32011 R 0137: Commission Regulation (EU) No 137/2011 of 16 February 2011 (OJ L 43, 17.2.2011, p. 1).’.

Article 2

The text of Regulation (EU) No 137/2011 in the Icelandic and Norwegian languages, to be published in the EEA Supplement to the Official Journal of the European Union, shall be authentic.

Article 3

This Decision shall enter into force on 11 February 2012, provided that all the notifications under Article 103(1) of the Agreement have been made to the EEA Joint Committee (*1).

Article 4

This Decision shall be published in the EEA Section of, and in the EEA Supplement to, the Official Journal of the European Union.

Done at Brussels, 10 February 2012.

For the EEA Joint Committee

The Acting President

Gianluca GRIPPA

---

(1)  
  OJ L 196, 28.7.2011, p. 32.

1

(2)  
  OJ L 43, 17.2.2011, p. 1.

2

(*1)  No constitutional requirements indicated.

*1

---
1 

UNITED STATES OF AMERICA 

Before the 

COMMODITY FUTURES TRADING COMMISSION 

 

In the Matter of the Exemption of Approved Exchanges 

and Locally-Incorporated Recognised Market Operators 

Authorized within Singapore from the 

Requirement to Register with the Commodity 

Futures Trading Commission as Swap Execution Facilities 

 

AMENDMENT TO APPENDIX A TO ORDER OF EXEMPTION

Commodity Exchange Act (“CEA”) section 5h(g) authorizes the Commodity Futures 

Trading Commission (“Commission”) to exempt, conditionally or unconditionally, a swap 

execution facility (“SEF”) from registration under CEA section 5h if the Commission finds that 

the facility is “subject to comparable, comprehensive supervision and regulation on a 

consolidated basis by ... the appropriate governmental authorities in the home country of the 

facility.” 

On March 13, 2019, the Commission issued an order of exemption (the “Order”) 

pursuant to CEA section 5h(g), with respect to approved exchanges (“AEs”) and recognized 

market operators (“RMOs”) authorized by the Monetary Authority of Singapore (“MAS”). 

In correspondence dated July 2, 2020 and October 23, 2020, MAS staff requested that the 

list of AEs and RMOs in Appendix A to the Order be amended to include the following 

3 

Amended Appendix A 

List of AEs and RMOs that are authorized and in good standing within Singapore that are 

subject to this Exemption Order 

Trading Venue Name and Category (i.e., AE or RMO) 

Asia Pacific Exchange Pte Ltd. (AE) 

BGC Partners (Singapore) Ltd. (RMO) 

Cleartrade Exchange Pte Ltd. (RMO) 

Euronext Markets Singapore Pte Ltd (RMO) 

GFI Group Pte Ltd. (RMO) 

ICAP (Singapore) Pte Ltd. (RMO) 

ICE Futures Singapore Pte Ltd. (AE) 

Nittan Capital Singapore Pte Ltd. (RMO) 

Refinitiv Transaction Services Pte Ltd. (RMO) 

Singapore Exchange Derivatives Trading Limited (AE) 

TFS Currencies Pte Ltd. (RMO) 

Tradition Singapore (Pte) Ltd (RMO) 

Tullett Prebon (Singapore) Limited (RMO)
COURT OF APPEALS

	SECOND DISTRICT OF TEXAS

	FORT WORTH

	NO. 2-07-146-CV

IN RE ROBERT SOLIS	RELATOR

	------------

	ORIGINAL PROCEEDING

	------------

	MEMORANDUM OPINION1

	------------

	The court has considered relator’s petition for writ of mandamus and is of the opinion that relief should be denied.  Accordingly, relator’s petition for writ of mandamus is denied.

								PER CURIAM

PANEL  B: LIVINGSTON, WALKER, and MCCOY, JJ.

DELIVERED: May 8, 2007
<TABLE> <S> <C>

<ARTICLE> 5
<MULTIPLIER> 1,000

<S>                             <C>
<PERIOD-TYPE>                   3-MOS
<FISCAL-YEAR-END>                          DEC-31-2000
<PERIOD-START>                             JAN-01-2000
<PERIOD-END>                               APR-01-2000
<CASH>                                           3,257
<SECURITIES>                                         0
<RECEIVABLES>                                    8,716
<ALLOWANCES>                                       345
<INVENTORY>                                      8,872
<CURRENT-ASSETS>                                20,958
<PP&E>                                           8,176
<DEPRECIATION>                                   5,275
<TOTAL-ASSETS>                                  23,899
<CURRENT-LIABILITIES>                          799,689
<BONDS>                                        248,781
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                        100
<COMMON>                                        55,948
<OTHER-SE>                                   (834,873)
<TOTAL-LIABILITY-AND-EQUITY>                    23,899
<SALES>                                         13,463
<TOTAL-REVENUES>                                13,509
<CGS>                                           10,675
<TOTAL-COSTS>                                   13,056
<OTHER-EXPENSES>                                     0
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                              20,021
<INCOME-PRETAX>                               (19,568)
<INCOME-TAX>                                         0
<INCOME-CONTINUING>                           (19,568)
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                  (19,568)
<EPS-BASIC>                                          0
<EPS-DILUTED>                                        0


</TABLE>